Answers are grounded in this paper and cite their sources.
Case report highlights recurrent in-stent restenosis in a woman, suggesting non-criteria antiphospholipid syndrome implications.
Background A 47-year-old female with no traditional CAD risk factors developed recurrent in-stent restenosis (ISR) one year after LAD stenting. She had recurrent pregnancy loss, chronic urticaria, anemia, and proteinuria, with negative conventional antiphospholipid antibodies. Case After second stenting, aPS/PT IgM was elevated (51.65 U/mL), supporting the diagnosis of non−criteria APS. Thromboelastography (TEG) showed decreased R time, increased MA and CI, suggestive of a hypercoagulable state. Warfarin (INR 2-3) and hydroxychloroquine (200 mg bid) plus DAPT led to no chest pain recurrence and stent patency at 21-month follow-up. Conclusions Recurrent ISR without traditional risk factors should raise suspicion for non−criteria APS. A moderately elevated aPS/PT IgM may serve as a diagnostic clue. Anticoagulation plus immunomodulation may help prevent further thrombotic events.
No takes yet. Share an insight, caveat, or question.
Tuo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: